Jan Lusti

Advised VT5 Acquisition Company AG, the first SIX-listed Swiss special purpose acquisition company, on the acquisition and public listing of R&S Group on SIX Swiss Exchange, including all aspects of its De-SPAC transaction, namely the acquisition, the capital raising, the repurchase and the debt financing.

Advised Schaffner Holding AG on the public tender offer for all of its publicly held shares by TE Connectivity.

Advised Luzerner Kantonalbank AG as arranger, agent, security agent and lender, and other Swiss and Liechtenstein banks as lender in connection with their EUR 150 million financing of GarLa AcquiCo AG and its subsidiaries.

Advised UBS on its landmark USD 50 million offering of digital securities (tokenized notes).

Acted for the issuer, underwriters or depositary bank in each of the four inaugural global depositary receipts (GDR) listings on SIX Swiss Exchange under China-Switzerland Stock Connect, consisting of the offerings by Gem Co., Gotion High-tech Co., Keda Industrial Group Co. and Ningbo Shanshan Co. with total proceeds of over USD 1.5 billion.

Advised Energy Infrastructure Partners AG co-founders and managing partners on acquisition of Credit Suisse AG's remaining 30% stake in the company.

Advised Feintool on its CHF 202 million rights offering.

Advised SIX-listed Cicor Technologies on its issuance of mandatory convertible notes with tradeable advance subscription rights.

Structured the first Special Purpose Acquisition Company (SPAC) under Swiss law and advised VT5 Acquisition Company, the first Swiss-listed SPAC, on its initial public offering.

Advised BNP Paribas and Deutsche Bank in connection with their approximately CHF 19 billion bridge facility for Roche Holding Ltd.

Advised UBS Switzerland AG, Credit Suisse (Switzerland) Ltd. and a syndicate of banks in CHF 1,5 billion revolving credit financing for Swiss International Air Lines AG and Edelweiss Air AG partially secured by the Swiss Confederation.

Advised Credit Suisse-led bank syndicate on CHF 265 million revolving credit financing for SR Technics Switzerland AG partially secured by the Swiss Confederation.

Advised SIX-listed Kuehne+Nagel on its acquisition of Apex International Corporation.

Advised SIX-listed Basilea Pharmaceuticals on its 2021 Private Investments in Public Equity (PIPE) share placement.

Advised Highbridge Capital Management on its equity-linked debt financing for SIXlisted Santhera Pharmaceuticals via senior secured exchangeable notes.

Represented SIX-listed Zur Rose Group on its accelerated book-building leading to a CHF 213 million capital increase.

Advised SIX-listed SCHMOLZ+BICKENBACH on all legal aspects of its CHF 325 million recapitalization through a rights offering.

Advised Ultima Capital on its listing and placements of shares.